The 2025 IV pilot measured cardiac, hepatic, renal, thyroid, and glucose biomarkers and reported no abnormalities (Lee et al., 2025), which gives a sense of what those investigators considered worth checking
I n the past few years, GLP-1 medications such as Wegovy and Zepbound have skyrocketed in popularity
So far its going great and already seeing changes
It is sold only as a research-use-only chemical and is not intended for human consumption
The study also showed several cardiometabolic benefits of semaglutide with significant improvement in hemoglobin A1C, body weight, and cholesterol reduction compared to placebo
"As GLP-1 medications become more common, restaurants that adapt to evolving consumer preferences may be better positioned to maintain guest visits and revenue," the report concluded